Health ❯ Healthcare ❯ Drug Safety

Adverse Reactions

Injection Site Reactions Immune-mediated Reactions Genetic Testing Monitoring and Precautions Myelosuppression Upper Respiratory Infections Neurologic Toxicities Infections Diarrhea and Hepatotoxicity Treatment Emergent Adverse Events Warnings and Precautions Monitoring Guidelines Hypersensitivity and Toxicity Clinical Study Results

3 ARTICLES

2mo ago

FDA Approves Durvalumab Plus BCG for High‑Risk Non‑Muscle Invasive Bladder Cancer

Phase 3 data showing lower recurrence alongside longer disease‑free survival support a new adjuvant immunotherapy option for patients who have not had BCG.

3 ARTICLES

2mo ago

FDA Clears First Biosimilars to Simponi and Simponi Aria: IMMGOLIS and IMMGOLIS INTRI

3 ARTICLES

4mo ago

Autolus Reports Q4 Loss, Reaffirms 2026 Sales Outlook for AUCATZYL, and Starts AUTO8 Trial

3 ARTICLES

4mo ago

FDA Approves Sotyktu for Active Psoriatic Arthritis as First TYK2 Inhibitor

5 ARTICLES

7mo ago

FDA Approves Rybrevant Faspro, a 5‑Minute Subcutaneous Amivantamab for EGFR‑Mutated Lung Cancer

5 ARTICLES

7mo ago

FDA Grants Full Approval to Jaypirca for Relapsed CLL/SLL After Covalent BTK Therapy

4 ARTICLES

9mo ago

Phase 3 Trial Finds Tukysa Improves PFS in First-Line Maintenance for HER2-Positive Metastatic Breast Cancer

6 ARTICLES

10mo ago

FDA Approves Palsonify, First Once-Daily Oral Treatment for Acromegaly